Trials / Completed
CompletedNCT03211702
Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)
Multi-center, Prospective Cohort Study-II to Investigate the Impact of Comprehensive Geriatric Assessments on Survival and Toxicities in Elderly Diffuse Large B-cell Lymphoma Patients Treated With R-CHOP (GERIAD2)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- —
Summary
This study will validate the impact of comprehensive geriatric assessments using activity of daily living (ADL), instrumental activity of daily living (IADL), and Charlson's comorbidity index (CCI) on survival and toxicities in Korean patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP.
Conditions
Timeline
- Start date
- 2017-08-25
- Primary completion
- 2018-04-30
- Completion
- 2020-12-30
- First posted
- 2017-07-07
- Last updated
- 2023-02-03
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03211702. Inclusion in this directory is not an endorsement.